2438
C. Schuster et al. / Tetrahedron: Asymmetry 17 (2006) 2430–2441
4.8.2.
(S)-2-((S)-2-Hydroxy-2-phenylhexanoylamino)-3-
NH–CO), 142.2 (s, Ph–C-1), 128.3/127.6/125.3 (3d, Ph–
C), 79.4 (s, Ph–C(CH2CH3)(OH)–CO–NH), 56.9 (d, NH–
CH(CH(CH3)2)COO), 52.1 (q, OCH3), 32.1 (t, CH2–
CH3), 31.2 (d, NH–CH(CH(CH3)2)COO), 18.8/17.6 (2q,
NH–CH(CH(CH3)2)COO), 7.6 (q, CH2–CH3).
methylbutyric acid, methyl ester, 15a. Colorless oil. 1H
NMR (200 MHz, CDCl3, TMS): dH = 7.54–7.50 (m, 2H,
aromatic), 7.33–7.19 (m, 3H, aromatic), 7.02 (d, 1H, NH,
J = 8.7 Hz), 4.38 (dd, 1H, NH–CH(CH(CH3)2)COO,
J1 = 8.9 Hz, J2 = 4.9 Hz), 3.64 (s, 3H, OCH3), 2.99 (s,
1H, OH), 2.26–1.94 (m, 3H, NH–CH(CH(CH3)2)COO,
CH2CH2CH2CH3), 1.35–1.14 (m, 4H, CH2CH2CH2CH3),
0.82 (t, 3H, CH2CH2CH2CH3, J = 6.8 Hz), 0.74/0.73 (2d,
6H, NH–CH(CH(CH3)2)COO, J = 6.9 Hz). 13C NMR
(50 MHz, CDCl3): dC = 174.1/172.3 (2s, O–CO, NH–
CO), 142.4 (s, Ph–C-1), 128.4/127.6/125.2 (3d, Ph–C),
79.1 (s, Ph–C(CH2CH2CH2CH3)(OH)–CO–NH), 57.0 (d,
NH–CH(CH(CH3)2)COO), 52.1 (q, OCH3), 39.1 (t,
CH2CH2CH2CH3), 31.2 (d, NH–CH(CH(CH3)2)COO),
25.5/22.8 (2t, CH2CH2CH2CH3), 18.8/17.6 (2q, NH–
CH(CH(CH3)2)COO), 13.9 (q, CH2CH2CH2CH3).
4.8.6.
(S)-2-((S)-2-Hydroxy-2-phenylpropionylamino)-3-
methylbutyric acid, methyl ester, 15e. Colorless oil. 1H
NMR (200 MHz, CDCl3, TMS): dH = 7.53–7.47 (m, 2H,
aromatic), 7.32–7.19 (m, 3H, aromatic), 7.07 (d, 1H, NH,
J = 8.7 Hz), 4.38 (dd, 1H, NH–CH(CH(CH3)2)COO,
J1 = 8.8 Hz, J2 = 4.8 Hz), 3.64 (s, 3H, OCH3), 2.16–1.96
(m, 1H, NH–CH(CH(CH3)2)COO), 1.74 (s, 3H, CH3),
0.74/0.73 (2d, 6H, NH–CH(CH(CH3)2)COO, J = 6.9 Hz).
13C NMR (50 MHz, CDCl3): dC = 174.7/172.3 (2s, O–
CO, NH–CO), 143.2 (s, Ph–C-1), 128.3/127.7/125.1 (3d,
Ph–C), 76.5 (s, Ph–C(CH3)(OH)–CO–NH), 57.0 (d, NH–
CH(CH(CH3)2)COO), 52.1 (q, OCH3), 31.3 (q, CH3),
27.1 (d, NH–CH(CH(CH3)2)COO), 18.8/17.5 (2q, NH–
CH(CH(CH3)2)COO).
4.8.3.
(S)-2-((S)-2-Hydroxy-3-methyl-2-phenylbutyryl-
amino)-3-methylbutyric acid, methyl ester, 15b. White so-
lid. 1H NMR (200 MHz, CDCl3, TMS): dH = 7.58–7.54
(m, 2H, aromatic), 7.30–7.10 (m, 4H, aromatic, NH),
4.32 (dd, 1H, NH–CH(CH(CH3)2)COO, J1 = 8.8 Hz,
J2 = 4.9 Hz), 3.62 (s, 3H, OCH3), 3.14 (s, 1H, OH), 2.77
(m, 1H, CH(CH3)2, J = 6.8 Hz), 2.10–1.89 (m, 1H, NH–
CH(CH(CH3)2)COO), 0.94/0.73 (2d, 6H, CH(CH3)2,
J = 6.8 Hz), 0.68/0.64 (2d, 6H, NH–CH(CH(CH3)2)COO,
J = 7.0 Hz). 13C NMR (50 MHz, CDCl3): dC = 174.0/
172.2 (2s, O–CO, NH–CO), 141.8 (s, Ph–C-1), 128.1/
127.2/125.2 (3d, Ph–C), 81.8 (s, Ph–C(i-Pr)(OH)–CO–
NH), 56.9 (d, NH–CH(CH(CH3)2)COO), 51.9 (q, OCH3),
34.6 (d, CH(CH3)2), 31.0 (d, NH–CH(CH(CH3)2)COO),
4.8.7.
(S)-2-((R)-2-Hydroxy-2-phenylpropionylamino)-3-
methylbutyric acid, methyl ester, 15f. Colorless oil. 1H
NMR (200 MHz, CDCl3, TMS): dH = 7.52–7.46 (m, 2H,
aromatic), 7.34–7.19 (m, 3H, aromatic), 6.77 (d, 1H, NH,
J = 8.6 Hz), 4.40 (dd, 1H, NH–CH(CH(CH3)2)COO,
J1 = 8.8 Hz, J2 = 4.8 Hz), 3.62 (s, 3H, OCH3), 2.20–1.96
(m, 1H, NH–CH(CH(CH3)2)COO), 1.77 (s, 3H, CH3),
0.79/0.73 (2d, 6H, NH–CH(CH(CH3)2)COO, J = 6.9 Hz).
13C NMR (50 MHz, CDCl3): dC = 174.7/172.1 (2s, O–
CO, NH–CO), 142.9 (s, Ph–C-1), 128.5/128.0/125.5 (3d,
Ph–C), 76.2 (s, Ph–C(CH3)(OH)–CO–NH), 57.1 (d, NH–
CH(CH(CH3)2)COO), 52.1 (q, OCH3), 31.2 (q, CH3),
26.8 (d, NH–CH(CH(CH3)2)COO), 18.9/17.5 (2q, NH–
CH(CH(CH3)2)COO).
18.7/17.6/16.8/15.7
CH(CH3)2).
(4q,
NH–CH(CH(CH3)2)COO,
4.8.4.
(S)-2-((S)-2-Cyclohexyl-2-hydroxy-2-phenylacetyl-
amino)-3-methylbutyric acid, methyl ester, 15c. White
solid. H NMR (200 MHz, CDCl3, TMS): dH = 7.58–7.53
4.9. Preparation of 5-bromo-2-methylpent-1-ene, 19
1
(m, 2H, aromatic), 7.31–7.13 (m, 4H, aromatic, NH),
4.33 (dd, 1H, NH–CH(CH(CH3)2)COO, J1 = 8.9 Hz,
J2 = 5.0 Hz), 3.64 (s, 3H, OCH3), 2.87 (s, 1H, OH), 2.45–
2.30 (m, 1H, c-Hex–CH), 2.12–1.94 (m, 1H, NH–
CH(CH(CH3)2)COO), 1.77–0.67 [m, 16H, c-Hex–CH2;
therein 0.73/0.69 (2d, 6H, NH–CH(CH(CH3)2)COO,
J = 7.0 Hz)]. 13C NMR (50 MHz, CDCl3): dC = 173.7/
172.2 (2s, O–CO, NH–CO), 141.4 (s, Ph–C-1), 128.2/
127.2/125.3 (3d, Ph–C), 81.8 (s, Ph–C(c-Hex)(OH)–CO–
NH), 56.9 (d, NH–CH(CH(CH3)2)COO), 52.0 (q, OCH3),
44.7 (d, c-Hex–CH), 31.2 (d, NH–CH(CH(CH3)2)COO),
29.7/27.2/26.3/26.3/25.9 (5t, c-Hex–CH2), 18.7/17.7 (2q,
NH–CH(CH(CH3)2)COO).
4.9.1. 4-Methylpent-4-enoic acid, ethyl ester,20 17.
A
mechanically stirred suspension of methyltriphenylphos-
phonium bromide (369 mmol/132 g) in dry THF
(500 mL) was cooled to ꢀ85 ꢂC. Then a 2.5 M solution
of n-BuLi (410 mmol/164 mL) was slowly added by main-
taining the temperature below ꢀ70 ꢂC and stirring was
continued for 1.5 h while cooling on an ice bath. After
the mixture had been cooled again to ꢀ60 ꢂC, a solution
of ethyl laevulinate 16 (289 mmol/41 mL) in dry THF
(150 mL) was slowly added by maintaining the temperature
below ꢀ60 ꢂC and stirring was continued overnight at
room temperature. Water (200 mL) was then added while
cooling on an ice bath. The organic layer was separated
and the aqueous layer extracted three times with ether.
The combined organic extracts were dried over Na2SO4, fil-
tered, and the solvents were evaporated under reduced
pressure (1013–380 mbar). The residue was taken up with
pentane (250 mL) and stirred for 1 h while cooling on an
ice bath. The remaining precipitate was filtered off, washed
with a little portion of cold pentane, and the solvent was
evaporated from the combined filtrates. The crude oil
was fractionated in vacuo. 23.9 g (yield 58%) colorless
oil, bp 75 ꢂC (35 mbar). 1H NMR (200 MHz, CDCl3,
TMS): dH = 4.76/4.71 (2s, 2H, CH3–C(@CH2)–CH2),
4.8.5. (S)-2-((S)-2-Hydroxy-2-phenylbutyrylamino)-3-meth-
1
ylbutyric acid, methyl ester, 15d. Colorless oil. H NMR
(200 MHz, CDCl3, TMS): dH = 7.54–7.49 (m, 2H, aro-
matic), 7.32–7.19 (m, 3H, aromatic), 7.08 (d, 1H, NH,
J = 8.7 Hz), 4.37 (dd, 1H, NH–CH(CH(CH3)2)COO,
J1 = 8.9 Hz, J2 = 5.0 Hz), 3.63 (s, 3H, OCH3), 2.36–2.13
(m, 1H, NH–CH(CH(CH3)2)COO), 2.13–1.92 (m, 2H,
CH2–CH3), 0.85 (t, 3H, CH2–CH3, J = 6.9 Hz), 0.74/0.73
(2d, 6H, NH–CH(CH(CH3)2)COO, J = 6.9 Hz). 13C
NMR (50 MHz, CDCl3): dC = 174.0/172.3 (2s, O–CO,